IndustryPayments
Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

MICHAEL A SASSOWER

Allopathic & Osteopathic Physicians Internal Medicine Interventional Cardiology

NPI
1710945159
CMS profile
123545
Location
UTICA, NY

General Payments · PY2018–2024

$12,555.65

  • Reported across 227 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$729.78

49 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

Related groups: Interventional Cardiology NY All categories

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $729.78 49

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
BOSTON SCIENTIFIC CORPORATION $276.60 3
NOVARTIS PHARMACEUTICALS CORPORATION $180.27 31
Edwards Lifesciences Corporation $79.05 4
PFIZER INC. $47.82 3
E.R. Squibb & Sons, L.L.C. $40.97 2
Abbott Laboratories $22.25 1
Kiniksa Pharmaceuticals International, plc $20.41 1
Merck Sharp & Dohme Corporation $16.25 1
Daiichi Sankyo Inc. $16.00 1
Lexicon Pharmaceuticals, Inc. $15.34 1
Alnylam Pharmaceuticals Inc. $14.82 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $7,801.46 52
PY2019 $2,350.39 34
PY2020 $211.87 9
PY2021 $419.57 21
PY2022 $566.37 33
PY2023 $476.21 29
PY2024 $729.78 49

Payment records · PY2024 (49)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Abbott Laboratories $22.25 04/18/2024 Food and Beverage Undisputed 01/23/2026 1125214595 CMS
Alnylam Pharmaceuticals Inc. $14.82 11/21/2024 Food and Beverage Undisputed 01/23/2026 1125824779 CMS
Boston Scientific Corporation $115.90 02/28/2024 Food and Beverage Undisputed 01/23/2026 1092299505 CMS
Boston Scientific Corporation $148.72 05/07/2024 Food and Beverage Undisputed 01/23/2026 1092299507 CMS
Boston Scientific Corporation $11.98 05/29/2024 Food and Beverage Undisputed 01/23/2026 1092299503 CMS
Daiichi Sankyo Inc. $16.00 10/02/2024 Food and Beverage Undisputed 01/23/2026 1089478673 CMS
E.R. Squibb & Sons, L.L.C. $17.56 04/10/2024 Food and Beverage Undisputed 01/23/2026 1101667413 CMS
E.R. Squibb & Sons, L.L.C. $23.41 07/18/2024 Food and Beverage Undisputed 01/23/2026 1101667461 CMS
Edwards Lifesciences Corporation $16.05 01/05/2024 Food and Beverage Undisputed 01/23/2026 1138775363 CMS
Edwards Lifesciences Corporation $17.98 04/05/2024 Food and Beverage Undisputed 01/23/2026 1138775377 CMS
Edwards Lifesciences Corporation $22.65 07/31/2024 Food and Beverage Undisputed 01/23/2026 1138775437 CMS
Edwards Lifesciences Corporation $22.37 08/13/2024 Food and Beverage Undisputed 01/23/2026 1138775443 CMS
Kiniksa Pharmaceuticals International, plc $20.41 06/21/2024 Food and Beverage Undisputed 01/23/2026 1154890563 CMS
Lexicon Pharmaceuticals, Inc. $15.34 03/26/2024 Food and Beverage Undisputed 01/23/2026 1081701499 CMS
Merck Sharp & Dohme LLC $16.25 05/16/2024 Food and Beverage Undisputed 01/23/2026 1141826742 CMS
Novartis Pharmaceuticals Corporation $0.95 02/13/2024 Food and Beverage Undisputed 01/23/2026 1087226719 CMS
Novartis Pharmaceuticals Corporation $11.34 02/13/2024 Food and Beverage Undisputed 01/23/2026 1087226721 CMS
Novartis Pharmaceuticals Corporation $4.50 03/27/2024 Food and Beverage Undisputed 01/23/2026 1087226729 CMS
Novartis Pharmaceuticals Corporation $1.22 03/27/2024 Food and Beverage Undisputed 01/23/2026 1087226735 CMS
Novartis Pharmaceuticals Corporation $10.46 04/04/2024 Food and Beverage Undisputed 01/23/2026 1087226727 CMS
Novartis Pharmaceuticals Corporation $0.88 04/04/2024 Food and Beverage Undisputed 01/23/2026 1087226733 CMS
Novartis Pharmaceuticals Corporation $0.90 04/09/2024 Food and Beverage Undisputed 01/23/2026 1087226731 CMS
Novartis Pharmaceuticals Corporation $4.77 04/09/2024 Food and Beverage Undisputed 01/23/2026 1087226737 CMS
Novartis Pharmaceuticals Corporation $5.10 04/19/2024 Food and Beverage Undisputed 01/23/2026 1087226747 CMS
Novartis Pharmaceuticals Corporation $0.86 04/19/2024 Food and Beverage Undisputed 01/23/2026 1087226749 CMS
Novartis Pharmaceuticals Corporation $0.80 05/23/2024 Food and Beverage Undisputed 01/23/2026 1087226753 CMS
Novartis Pharmaceuticals Corporation $5.12 05/23/2024 Food and Beverage Undisputed 01/23/2026 1087226755 CMS
Novartis Pharmaceuticals Corporation $11.50 06/04/2024 Food and Beverage Undisputed 01/23/2026 1087226751 CMS
Novartis Pharmaceuticals Corporation $0.92 06/20/2024 Food and Beverage Undisputed 01/23/2026 1087226759 CMS
Novartis Pharmaceuticals Corporation $4.82 06/20/2024 Food and Beverage Undisputed 01/23/2026 1087226765 CMS
Novartis Pharmaceuticals Corporation $0.09 06/25/2024 Food and Beverage Undisputed 01/23/2026 1087226761 CMS
Novartis Pharmaceuticals Corporation $12.65 06/25/2024 Food and Beverage Undisputed 01/23/2026 1087226767 CMS
Novartis Pharmaceuticals Corporation $0.87 07/11/2024 Food and Beverage Undisputed 01/23/2026 1087226763 CMS
Novartis Pharmaceuticals Corporation $4.19 07/11/2024 Food and Beverage Undisputed 01/23/2026 1087226769 CMS
Novartis Pharmaceuticals Corporation $5.78 07/30/2024 Food and Beverage Undisputed 01/23/2026 1087226775 CMS
Novartis Pharmaceuticals Corporation $0.89 07/30/2024 Food and Beverage Undisputed 01/23/2026 1087226779 CMS
Novartis Pharmaceuticals Corporation $0.89 08/05/2024 Food and Beverage Undisputed 01/23/2026 1087226777 CMS
Novartis Pharmaceuticals Corporation $5.59 08/05/2024 Food and Beverage Undisputed 01/23/2026 1087226781 CMS
Novartis Pharmaceuticals Corporation $10.06 08/26/2024 Food and Beverage Undisputed 01/23/2026 1087226785 CMS
Novartis Pharmaceuticals Corporation $0.89 09/26/2024 Food and Beverage Undisputed 01/23/2026 1087226787 CMS
Novartis Pharmaceuticals Corporation $5.11 09/26/2024 Food and Beverage Undisputed 01/23/2026 1087226789 CMS
Novartis Pharmaceuticals Corporation $27.44 10/21/2024 Food and Beverage Undisputed 01/23/2026 1087226795 CMS
Novartis Pharmaceuticals Corporation $4.89 10/29/2024 Food and Beverage Undisputed 01/23/2026 1087226803 CMS
Novartis Pharmaceuticals Corporation $18.69 11/11/2024 Food and Beverage Undisputed 01/23/2026 1087226797 CMS
Novartis Pharmaceuticals Corporation $4.49 11/14/2024 Food and Beverage Undisputed 01/23/2026 1087226805 CMS
Novartis Pharmaceuticals Corporation $13.61 11/15/2024 Food and Beverage Undisputed 01/23/2026 1087226807 CMS
PFIZER INC. $18.14 01/17/2024 Food and Beverage Undisputed 01/23/2026 1130977988 CMS
PFIZER INC. $14.47 06/05/2024 Food and Beverage Undisputed 01/23/2026 1131460667 CMS
PFIZER INC. $15.21 12/05/2024 Food and Beverage Undisputed 01/23/2026 1131012064 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.